humanized mAb RTK inhibitors (Celldex Therapeutics)

N/A

Report date: 2025/03/20 15:50:55

Base Information

Drug Namehumanized mAb RTK inhibitors (Celldex Therapeutics)

Drug Alias Namehumanized mAb RTK inhibitors (Kolltan)tyrosine kinase receptor-inhibiting humanized monoclonal antibodies (Kolltan)tyrosine kinase receptor-inhibiting humanized mAbs (Kolltan)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionNerve growth factor receptor Trk-A inhibitors

TargetsNerve growth factor receptor Trk-A

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKolltan Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesCelldex Therapeutics Inc

Inactive CompaniesKolltan Pharmaceuticals Inc

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A